Monte Rosa Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Monte Rosa Therapeutics by Tower Research Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $50k | 14k | 3.74 |
2024-03-31 | $3.7k | 522 | 7.05 |
2023-09-30 | $82k | 17k | 4.79 |
2023-06-30 | $11k | 1.7k | 6.85 |
2023-03-31 | $18k | 2.3k | 7.68 |
2022-12-31 | $11k | 1.5k | 7.55 |
2022-09-30 | $121k | 15k | 8.16 |
2022-06-30 | $70k | 7.2k | 9.66 |
2022-03-31 | $37k | 2.6k | 14.15 |
2021-12-31 | $9.0k | 458 | 19.65 |
2021-09-30 | $32k | 1.4k | 22.76 |
2021-06-30 | $9.0k | 400 | 22.50 |